Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enovis (DE:C520)
FRANKFURT:C520
Enovis (C520) Stock Price & Analysis
0 Followers
C520 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€41.20 - €59.00
Previous Close€51
Volume0.00
Average Volume (3M)164.00
Market Cap
€2.65B
Enterprise Value€3.06B
Total Cash (Recent Filing)$36.19M
Total Debt (Recent Filing)$466.16M
Price to Earnings (P/E)N/A
Beta1.05
Next Earnings
Aug 01, 2024EPS EstimateN/A
Last Dividend Ex-Date
Apr 05, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding54,850,906
10 Day Avg. Volume20
30 Day Avg. Volume164
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)12.37
Price to Sales (P/S)1.64
Price to Cash Flow (P/CF)10.40
P/FCF Ratio16.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.79
Enterprise Value/Gross Profit3.08
Enterprise Value/Ebitda18.00
Forecast
1Y Price Target
€71.56Price Target Upside48.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Enovis News
Bulls Say, Bears Say
Bulls Say
Acquisition SynergyExpectations for revenue and cost synergies from the Lima acquisition.
Financial Strategy And GrowthSustainable financial strategy targeting high single-digit growth and significant EBITDA margin improvement.
Innovation And Market ExpansionContinuous innovation and portfolio diversification have led to significant market share gains in key segments.
Bears Say
Earnings PerformanceEMBLA's Bracing & Support sales only increased 1% organically, below the analyst's estimate of 3.5% for ENOV's P&R business.
Financial GuidanceConcerns are present about management possibly being too conservative in its 2024 guidance for Lima and potential dis-synergies.
Tax Rate ImpactTax is expected to be a 100-200 bps headwind in the upcoming year.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
7.54% Other Institutional Investors
92.46% Public Companies and
Individual Investors
C520 FAQ
What was Enovis’s price range in the past 12 months?
Enovis lowest stock price was €41.20 and its highest was €59.00 in the past 12 months.
What is Enovis’s market cap?
Currently, no data Available
When is Enovis’s upcoming earnings report date?
Enovis’s upcoming earnings report date is Aug 01, 2024 which is in 88 days.
How were Enovis’s earnings last quarter?
Enovis released its earnings results on May 02, 2024. The company reported €0.467 earnings per share for the quarter, beating the consensus estimate of €0.452 by €0.015.
Is Enovis overvalued?
According to Wall Street analysts Enovis’s price is currently Undervalued.
Does Enovis pay dividends?
Enovis pays a Notavailable dividend of €15.55 which represents an annual dividend yield of N/A. See more information on Enovis dividends here
What is Enovis’s EPS estimate?
Enovis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enovis have?
Currently, no data Available
What happened to Enovis’s price movement after its last earnings report?
Enovis reported an EPS of €0.467 in its last earnings report, beating expectations of €0.452. Following the earnings report the stock price went down -0.971%.
Which hedge fund is a major shareholder of Enovis?
Among the largest hedge funds holding Enovis’s share is Diamond Hill Capital Management Inc. It holds Enovis’s shares valued at 140M.
---
Enovis Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€71.56 (48.45% Upside)
€71.56 (48.45% Upside)
Blogger Sentiment
Bullish
DE:C520 Sentiment 100%
Sector Average 69%
Sector Average 69%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.16%
12-Months-Change
Fundamentals
Return on Equity
-3.06%
Trailing 12-Months
Asset Growth
27.42%
Trailing 12-Months
Company Description
Enovis
Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.
---
C520 Company Deck
---
C520 Earnings Call
Q1 2024
0:00 / 0:00
---
C520 Stock 12 Months Forecast
Average Price Target
€71.56
▲(48.45% Upside)
Technical Analysis
Best Analysts Covering C520
1 Year
---